1. Elisabet Jakova†, Omozojie P. Aigbogun†, Mohamed Taha Moutaoufik, Kevin J.H. Allen, Omer Munir, Devin Brown, Changiz Taghibiglou, Mohan Babu, Chris P. Phenix, Ed S. Krol and Francisco S. Cayabyab (2024): “The Bifunctional Dimer Caffeine-Indan Attenuates α-Synuclein Misfolding, Neurodegeneration and Behavioural Deficits after Chronic Stimulation of Adenosine A1 Receptors”, International Journal of Molecular Sciences, https://doi.org/10.3390/ijms25179386 (Co-First Author)

2. Omozojie P. Aigbogun†, Ed S. Krol, Christopher P. Phenix, Eric Price (2023): “The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules”, Molecular Pharmaceutics, https://doi.org/10.1021/acs.molpharmaceut.2c00821, (First Author)

3. Omozojie P. Aigbogun†, Chukwunonso K. Nwabufo, Madeline N. Owens, Christopher P. Phenix & Ed S. Krol (2022):  “An HPLC-UV validated bioanalytical method for measurement of in vitro Phase 1 kinetics of α-Synuclein binding bifunctional compounds”, Xenobiotica, DOI.org/10.1080/00498254.2022.2140315 (First Author)

4. Chukwunonso K. Nwabufo, Omozojie P. Aigbogun (2022): “Potential application of mass spectrometry imaging in pharmacokinetic studies”, Xenobiotica, DOI: 10.1080/00498254.2022.2119900 (Co-Author)

5. Chukwunonso K. Nwabufo, Omozojie P. Aigbogun (2022): “Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease”, Journal of Neurology, DOI: 10.1007/s00415-022-11267-9 (Co-Author)

6. Chukwunonso K. Nwabufo†, Omozojie P. Aigbogun†, Kevin J.H Allen, Madeline N. Owens, Jeremy S. Lee, Christopher P. Phenix & Ed S. Krol (2021): “Employing in vitro metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compounds”, Xenobiotica, DOI: 10.1080/00498254.2021.1943566 (Co-First Author)

1. “One-pot synthesis of [11C]amides via copper(I) catalyzed direct incorporation of [11C]CO2” Omozojie P. Aigbogun, Neil Vasdev, and Anton Lindberg. Canadian Chemistry Conference and Exhibition, Winnipeg, Canada, June 2 – 6, 2024, Abstract ID: 769 (Oral Presentation)

2. “Synthesis and biological evaluation of dimethylxanthine derivatives as potential diagnostic radiotracers for Parkinson’s Disease” Samira Poorsadeghi Markhali, Omozojie P. Aigbogun, Christopher P. Phenix, and Ed S. Krol. Canadian Chemistry Conference and Exhibition, Winnipeg], Canada, June 2 – 6, 2024, Abstract ID: 1134 (Poster Presentation)

3. “Preclinical investigation of alpha-synuclein 18F labelled bifunctional agents as Positron Emission Tomography Imaging Probes for Parkinson’s Disease: Synthesis, Pharmacokinetics, and biodistribution” Omozojie P. Aigbogun, Christopher P. Phenix, and Ed S. Krol. DMDG open Meeting, Amsterdam, Netherlands, October 3 – 5, 2022, Abstract #18 (Poster Presentation)

4. “18F Labelled Bifunctional Agents as Positron Emission Tomography Probes for Parkinson Disease: Synthesis, Pharmacokinetics and Biodistribution” Omozojie P. Aigbogun, Christopher P. Phenix, and Ed S. Krol. Canadian Chemistry Conference and Exhibition, Calgary, Canada, June 13 – 17, 2022, Abstract ID: 978 (Poster Presentation)

5. “An HPLC-UV method for measurement of in vitro Phase 1 kinetics of α-synuclein binding bifunctional compounds” Omozojie P. Aigbogun, Christopher P. Phenix, and Ed S. Krol. DMDG open Meeting, , United Kingdom (remotely), October 18 – 20, 2021Abstract #8 (Poster Presentation and Student Poster Blitz)

6. “Alpha-synuclein Binding 18F Labelled Bifunctional Agents as Positron Emission Tomography Imaging Probes for Parkinson’s disease” Omozojie P. Aigbogun, Christopher P. Phenix, and Ed S. Krol. Usask Canadian Chemistry Conference and Exhibition, Winnipeg, Canada, May 26, 2020, Abstact ID: 555 (Accepted abstract for oral Presentation)

7. “Microsomal Metabolism Studies of Bifunctional Compounds for Parkinson’s disease” Maddy Owens, Omozojie P. Aigbogun, Ed S. Krol. University of Saskatchewan undergraduate research poster competition (3rd position poster, presentation by Maddy Owens)

8. “Alpha-synuclein Binding 18F Labelled Bifunctional Agents as Positron Emission Tomography Imaging Probes for Parkinson’s disease” Omozojie P. Aigbogun, Christopher P. Phenix, and Ed S. Krol. Usask. Sixth Western Canadian Medicinal Chemistry Workshop, Saskatchewan, Canada Sept 22-23, 2018, Abstract #3 (Poster Presentation and Poster Award)

9. “Alpha-synuclein Binding 18-F Labelled Bifunctional Agents as Positron Emission Tomography Imaging Probes for Parkinson’s disease” Omozojie P. Aigbogun, Christopher P. Phenix, and Ed S. Krol. Usask Canadian Society for Chemistry Conference, Edmonton, Canada, May 28, 2018, Abstract ID: CSC18981 (Poster Presentation)

10. “Alpha-synuclein Binding 18F Labelled Bifunctional Agents as Positron Emission Tomography Imaging Probes for Parkinson's disease” Omozojie P. Aigbogun, Christopher P. Phenix, and Ed S. Krol. Usask, Life and Health Sciences Research Expo, Saskatchewan, Canada, May 3, 2018, Abstract #55 (Poster Presentation)

11. “Designing a Synthetic Methodology for the preparation of Alpha-Synuclein Binding 18F Labelled Bifunctional Agents as Positron Emission Tomography Imaging Probes for Parkinson’s disease” Omozojie P. Aigbogun, Christopher P. Phenix, and Ed S. Krol. Usask 2nd Annual Neuroscience Research Symposium, Saskatchewan, Canada, Nov. 2-3 2017, Abstract #P53 (poster) (Poster Presentation)